ACRX - AcelRx Pharmaceuticals GAAP EPS of -$0.41 beats by $0.12 revenue of $0.25M beats by $0.18M August, 10 2023 04:09 PM AcelRx Pharmaceuticals Inc. 2023-08-10 16:09:11 ET AcelRx Pharmaceuticals press release ( NASDAQ: ACRX ): Q2 GAAP EPS of -$0.41 beats by $0.12 . Revenue of $0.25M beats by $0.18M . For further details see: AcelRx Pharmaceuticals GAAP EPS of -$0.41 beats by $0.12, revenue of $0.25M beats by $0.18M